Clinical research for surgeons in palliative care: Challenges and opportunities

Journal of the American College of Surgeons

Volumn 196, Issue 1, 2003, Pages 141-151

  Easson, Alexandra M ^a   Lee, K Francis ^b   Brasel, Karen ^b   Krouse, Robert S ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; MEDICAL PRACTICE; MORBIDITY; MORTALITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0037229935     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01703-9     Document Type: Article

References (100)

1. Friel JP. Dorland's illustrated medical dictionary. 26th ed. Philadelphia: WB Saunders; 1985.
2. Lye M. Chronic cardiac failure in the elderly. In: Tallis R, Fillit H, Brocklehurst J, eds. Brocklehurst's textbook of geriatric medicine and gerontology. Edinburgh: Churchill Livingstone; 1998:288-312.
3. Deaths: Leading causes for 1999, National Vital Statistics Report. Accessed on 9/25/02 from: www.cdc.gov/nchs/data/nvsr/nvsr49/nvsr49_11.pdf.2001.
4. Lynn J. Learning to care for people with chronic illness facing the end of life. JAMA 2000;284:2508-2511.
5. Covinsky KE, Fuller JD, Yaffe K, et al. Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000;48(5 Suppl):S187-S193.
6. Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 2000;89:561-573.
7. Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 1997;15:1252-1260.
8. Mazur DJ, Metz JF. How the manner of presentation of data influences older patients in determining their treatment preferences. J Am Geriatr Soc 1993;41:223-228.
9. Terry PB, Vettese M, Song J, et al. End-of-life decision making: when patients and surrogates disagree. J Clin Ethics 1999;10:286-293.
10. Levine RS. Avoiding conflicts of interest in surrogate decision making: why ethics committees should assign surrogacy to a separate committee. J Clin Ethics 1998;9:273-290.
11. Rogers J, Ridley S, Chrispin P, et al. Reliability of the next of kins' estimates of critically ill patients' quality of life. Anaesthesia 1997;52:1137-1143.
12. Haidet P, Hamel MB, Davis RB, et al. Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med 1998;105:222-229.
13. Jacobs TJ. On misreading and misleading patients. Some reflections on communications, miscommunications and countertransference enactments. Int J Psychoanal 2001;82:653-669.
14. Shiminski-Maher T. Physician-patient-parent communication problems. Pediatr Neurosurg 1993;19:104-108.
15. Weeks JC, Cook EF, O'Day SJ. Relationship between cancer patients prediction of prognosis and their treatment preferences. JAMA 1998;279:1709-1714.
16. Ptacek JT, Eberhardt TL. Breaking bad news. A review of the literature. JAMA 1996;276:496-502.
17. Vigano A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000;160:861-868.
18. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. Br Med J 2000;320:469-472.
19. Sloan JA, Loprinzi CL, Laurine JA, et al. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol 2001;19:3539-3546.
20. Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999;7:128-133.
21. Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage 1999;17:240-247.
22. Knaus WA, Harrell FE Jr, Lynn J, et al. The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Ann Intern Med 1995;122:191-203.
23. Vigano A, Dorgan M, Buckingham J, et al. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 2000;14:363-374.
24. Fox E, Landrum-McNiff K, Zhong Z, et al. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA 1999;282:1638-1645.
25. Seidman AD, Portenoy R, Yao TJ, et al. Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 1995;87:1316-1322.
26. Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995;10:423-431.
27. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer 1990;62:695-699.
28. Child CG, Turcotte JC. Surgery and portal hypertension. In: Child CGI, ed. Major problems in clinical surgery: the liver and portal hypertension. Philadelphia: WB Saunders; 1964:1-85.
29. Turcotte JG, Raper SE, Eckhauser FE. Portal hypertension In: Greenfield LJ, Mulholland MW, Oldham KT, Zenelock GB, eds. Surgery, scientific principles and practice. Philadelphia: JB Lippincott Co; 1996:887-908.
30. Miner TJ, Jaques DP, Tavaf-Motamen H, Shriver CD. Decision making on surgical palliation based on patient outcome data. Am J Surg 1999;177:150-154.
31. Michael M, Tannock IF. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ 1998;158:1727-1734.
32. Osoba D. Rationale for the timing of health-related quality-of-life (HQL) assessments in oncological palliative therapy. Cancer Treat Rev 1996;22(Suppl A):69-73.
33. Seely JF, Mount BM. Palliative medicine and modern technology. Can Med Assoc J 1999;161:1120-1121.
34. McLeod RS. Quality-of-life measurement in the assessment of surgical outcome. Adv Surg 1999;33:293-309.
35. Shekarriz B, Shekarriz H, Upadhyay J, et al. Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 1999;85:998-1003.
36. Prat F, Chapat O, Ducot B, et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 1998;42:76-80.
37. Bolder U, Brune A, Schmidt S, et al. Preoperative assessment of mortality risk in hepatic resection by clinical variables: a multivariate analysis. Liver Transpl Surg 1999;5:227-237.
38. Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2000;4:CD002764.
39. SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA 2000;274:1591-1598.
40. Leach D. The ACGME competencies: substance or form? Accreditation Council for Graduate Medical Education. J Am Coll Surg 2001;192:396-398.
41. The American Board of Surgery: Booklet of information. July 2002-June 2003. Philadelphia, PA: The American Board of Surgery Inc; 2002.
42. Cox S, Pories W. Surgical resident curriculum. 3rd edition. Arlington, VA: The Association of Program Directors in Surgery; 1999.
43. Rappaport W, Prevel C, Witzke D, et al. Education about death and dying during surgical residency. Am J Surg 1991;161:690-692.
44. Sloan PA, Donnelly MB, Schwartz RW, Sloan DA. Residents' management of the symptoms associated with terminal cancer. Hospice J 1997;12:5-15.
45. Sloan PA, Donnelly MB, Schwartz RW, Sloan PA. Cancer pain assessment and management by housestaff. Pain 1996;67:475-481.
46. Helme RD, Gibson SJ. The epidemiology of pain in elderly people. Clin Geriatr Med 2001;17:417-431.
47. Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993;217:447-455.
48. Brown DL, Caswell RE, Wong GY, et al. Referral of patients with pain from pancreatic cancer for neurolytic celiac plexus block. Mayo Clin Proc 1997;72:831-834.
49. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996;7:347-353.
50. Ferris FD, Bezjak A, Rosenthal SG. The palliative uses of radiation therapy in surgical oncology patients. Surg Oncol Clin N Am 2001;10:185-201.
51. Auchter RM, Scholtens D, Adak S, et al. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 2001;50:1199-1206.
52. Easson AM, Asch M, Swallow CJ. Palliative general surgical procedures. Surg Oncol Clin North Am 2001;10:161-184.
53. Gouma DJ, van Geenen R, van Gulik T, et al. Surgical palliative treatment in bilio-pancreatic malignancy. Ann Oncol 1999;10S4:269-272.
54. Cubiella J, Castells A, Fondevila C, et al. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol 1999;94:1271-1278.
55. Krouse RS, McCahill LE, Easson AM, Dunn GP. When the sun can set on an unoperated bowel obstruction: management of malignant bowel obstruction. J Am Coll Surg 2002;195:117-128.
56. Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995;9:207-219.
57. Byock IR, Merriman MP. Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index. Palliat Med 1998;12:231-244.
58. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6-9.
59. Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
60. Kyriaki M, Eleni T, Efi P, et al. The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample. Int J Cancer 2001;94:135-139.
61. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994;30A:1326-1336.
62. Chang VT, Hwang SS, Feuerman M, et al. The memorial symptom assessment scale short form (MSAS-SF). Cancer 2000;89:1162-1171.
63. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
64. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990;62:1034-1038.
65. Murphy DJ, Burrows D, Santilli S, et al. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med 1994;330:545-549.
66. Emanuel LL, Barry MJ, Stocckle JD, et al. Advance directives for medical care - a case for greater use. N Engl J Med 1991;324:889-895.
67. Lipsett PA, Swoboda SM, Dickerson J, et al. Survival and functional outcome after prolonged intensive care unit stay. Ann Surg 2000;231:262-268.
68. Haley SM, McHorney CA, Ware JE Jr. Evaluation of the MOS SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale. J Clin Epidemiol 1994;47:671-684.
69. Lipsett PA, Swoboda SM, Campbell KA, et al. Sickness Impact Profile Score versus a Modified Short-Form survey for functional outcome assessment: acceptability, reliability, and validity in critically ill patients with prolonged intensive care unit stays. J Trauma 2000;49:737-743.
70. Fakhry SM, Kercher KW, Rutledge R. Survival, quality of life, and charges in critically ill surgical patients requiring prolonged ICU stays. J Trauma 1996;41:999-1007.
71. Keenan SP, Busche KD, Chen LM, et al. A retrospective review of a large cohort of patients undergoing the process of withholding or withdrawal of life support. Crit Care Med 1997;25:1324-1331.
72. Mittelberger JA, Lo B, Martin D, Uhlmann RF. Impact of a procedure-specific do not resuscitate order form on documentation of do not resuscitate orders. Arch Intern Med 1993;153:228-232.
73. Rapoport J, Teres D, Lemeshow S. Resource use implications of do not resuscitate orders for intensive care unit patients. Am J Respir Crit Care Med 1996;153:185-190.
74. Jayes R, Zimmerman J, Wagner D, Knaus W. Variations in the use of do-not-resuscitate orders in the ICU: findings from a national study. Chest 1996;110:1332-1339.
75. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001;29:277-282.
76. Desbiens NA, Wu AW, Broste SK, et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Crit Care Med 1996;24:1953-1961.
77. Puntillo KA. Pain experiences of intensive care unit patients. Heart Lung 1990;19:526-533.
78. Whipple JK, Lewis KS, Quebbeman EJ, et al. Analysis of pain management in critically ill patients. Pharmacotherapy 1995;15:592-599.
79. Uhlmann RF, Pearlman RA, Cain KC. Physicians' and spouses' predictions of elderly patients' resuscitation preferences. J Gerontol 1998;43:M115-M121.
80. Koch KA, Rodeffer HD, Wears RL. Changing patterns of terminal care management in an intensive care unit. Crit Care Med 1994;22:233-243.
81. Curtis JR, Patrick DL, Shannon SE, et al. The family conference as a focus to improve communication about end-of-life care in the intensive care unit: opportunities for improvement. Crit Care Med 2001;29(2 Suppl):N26-N33.
82. Casarett DJ, Karlawish JH. Are special ethical guidelines needed for palliative care research? J Pain Symptom Manage 2000;20:130-139.
83. Janssens R, Gordijn B. Clinical trials in palliative care: an ethical evaluation. Patient Educat Counsel 2000;41:55-62.
84. Kristjanson LJ, Hanson EJ, Balneaves L. Research in palliative care populations: ethical issues. J Palliat Care 194;10:10-15.
85. Lawton J. Gaining and maintaining consent: ethical concerns raised in a study of dying patients. Qual Health Res 2001;11:693-705.
86. McCahill LE, Krouse RS, Chu DZ, et al. Decision making in palliative surgery. J Am Coll Surg 2002;195:411-422.
87. McLeod RS. Issues in surgical randomized controlled trials. World J Surg 1999;23:1210-1214.
88. de Raeve L. Ethical issues in palliative care research. Pall Med 1994;8:298-305.
89. Clark D, Ingleton C, Seymour J. Support and supervision in palliative care research. Palliat Med 2000;14:441-446.
90. Foley KM, Gelband H, eds. Improving palliative care for cancer, summary and recommendations. National Cancer Policy Board, Institute of Medicine and National Research Council. Washington, DC: National Academy Press; 2001.
91. Rhymes JA. Barriers to palliative care. Cancer Control 1996;3:230-23.
92. Rubenfeld GD, Randall CJ. End-of-life care in the intensive care unit: a research agenda. Crit Care Med 2001;29:2001-2006.
93. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981;34:585-597.
94. Weeks JC, O'Leary J, Fairclough D, et al. A new tool for assessing health-related quality of life and utilities in clinical trials and clinical practice. Proc Am Soc Clin Oncol 1994;13:436.
95. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: development and validation. J Clin Oncol 1984;2:472-483.
96. Baum M, Priestman T, West RR, Jones EM. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer 1984;2(Suppl 1):223-226.
97. Padilla GV, Grant MM. Quality of life as a cancer nursing outcome variable. Adv Nurs Sci 1985;8:45-60.
98. Gelber RD, Goldhirsch A, Cole BF. Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group. Cancer Treat Rev 1993;19(Suppl A):73-84.
99. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995;82:216-222.
100. Sloan JA, Loprinzi CL, Kuross SA, et al. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 1998;16:3662-3673.